KYNB logo
KYNB NASDAQ US

Kyntra Bio, Inc. - Common Stock

Website · IPO Nov 2014
$7.01
▼ $-0.09 (-1.27%)
Vol 12K

Wall Street Consensus

8 analysts · Apr 2026
2
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating

Price Chart

Earnings

Beat rate: 100.0%
Next Report May 11, 2026
EPS Estimate: $-3.42
Quarter EPS Est EPS Act Surprise
Mar 2026 $-3.42
Dec 2025 $-3.96 $-3.61 +$0.35
Sep 2025 $-4.09 $-3.25 +$0.84
Jun 2025 $-2.35 $-1.88 +$0.47

Quarterly Revenue & Earnings

Quarter 2024-0… 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Revenue -$123.3M $2.7M $1.3M $1.1M $1.3M
Net Income $18.0M $4.6M -$7.6M $200.6M -$14.2M

Financial Health

Free Cash Flow
-$18.3M
Cash
$47.9M
As of Dec 31, 2025

Peer Comparison

Ticker Mkt Cap P/E P/S ROE Margin Beta
KYNB
BTAI $35.0M 46.5 -309.0% -9070.6% 0.25
ABVC $51.8M 64.9 -64.1% -127.5% 0.20
SHPH $2.9M -476.1% 0.53
XCUR $34.5M 69.1 -108.8% -165.8% 4.29

Latest News

No related news yet